The Symptoms Of Multiple Sclerosis Blog

The European Commission has approved Extavia® (interferon beta-1b) for the treatment of early and relapsing forms of multiple sclerosis (MS) – the first in a new portfolio of medicines from Novartis that is planned to include both established treatments and innovative therapies for patients with MS. Extavia is the Novartis branded version of interferon beta-1b, a first-line disease-modifying therapy injected every other day for the treatment of MS.

The MS Society has called on MPs to throw their weight behind the Human Fertilisation and Embryology Bill, which will be debated in the House of Commons. In a letter addressed to every Member of Parliament, the MS Society is among seven charities asking politicians to support the Bill, which if approved could open new avenues of research into conditions such as multiple sclerosis (MS).

The MS Society welcomes the decision by MPs to allow scientists to use ‘hybrid’ human – animal embryos in research into conditions such as multiple sclerosis (MS).Jayne Spink, Director of Policy and Research at the MS Society, said: “This really is a victory for common sense.

The results of an international survey presentedby Bayer Schering Pharma shows that many people face the same fears andconcerns when they are first diagnosed with multiple sclerosis (MS). In thesurvey, 71 percent of people with MS had at least one concern about how thedisease would affect their relationships; 64 percent said being diagnosedhad a negative impact on their career. To address these concerns, BayerSchering Pharma launched Mastering MS today.

Multiple sclerosis (MS) typically starts in young adulthood, but about five percent of cases start in childhood or the teen years. Children with MS are at risk to exhibit low IQ scores and problems with memory, attention and other thinking skills, according to a study published in the May 13, 2008, issue of Neurology®, the medical journal of the American Academy of Neurology.

On Saturday, May 10th, 2008 Mr. Lube Canada will be supporting the Multiple Sclerosis (MS) Society of Canada and MS Awareness Month by donating $5 from every oil change purchase at Mr. Lube locations across the country. Canada has one of the highest rates of MS in the world and women are diagnosed with the disease three times more frequently than men. These are two stark facts that serve as motivation for those who work to end the disease and primary reasons for Mr.

A new study published in the Journal of Neurology Neurosurgery and Psychiatry finds that Prozac, a commonly prescribed antidepressant, may be an agent in slowing down the disease process of the relapsing remitting form of multiple sclerosis (MS).Multiple sclerosis is an autoimmune disease where the immune system attacks the central nervous system. In the relapsing remitting form,new symptoms occur in discrete attacks.

Technorati Tags: multiple sclerosis, prozac

Del.icio.us Tags: autoimmune disease, central nervous system

Flickr Tags: neurology, relapsing remitting multiple sclerosis